Literature DB >> 8423785

The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element.

J Dalmon1, M Laurent, G Courtois.   

Abstract

Acute-phase reactants are liver proteins whose synthesis is positively or negatively regulated during inflammation. The main mediators of this phenomenon are glucocorticoids and interleukin-6 (IL-6), a pleiotropic cytokine that also controls hematopoiesis. Functional analysis of several acute-phase reactant promoter regions has identified two major DNA motifs used by IL-6-regulated genes. The first one corresponds to a CTGG(G/A)AA sequence, and the other is a binding site for members of the C/EBP family of nuclear proteins. We have previously shown that the human beta fibrinogen (beta Fg) promoter contains an IL-6-responsive region, located between bp -150 and -67 (P. Huber, M. Laurent, and J. Dalmon, J. Biol. Chem. 265:5695-5701, 1990). In this study, using DNase I footprinting, mobility shift assays, and mutagenesis, we demonstrate that at least three subdomains of this region are necessary to observe a full response to IL-6. The most distal contains a CTGGGAA motif, and its mutation inhibits IL-6 stimulation. Another, which is able to interact with several distinct nuclear proteins, among them members of the C/EBP family, is dispensable for IL-6 induction but plays an important role in the constitutive expression of beta Fg. Finally, a proximal hepatocyte nuclear factor 1 binding site, already described as the major determinant of beta Fg tissue-specific expression, is also required for IL-6 stimulation. These results indicate a complex interplay between nuclear proteins within the beta Fg IL-6-responsive region and suggest a tight functional coupling between the tissue-specific and inducible elements.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423785      PMCID: PMC359003          DOI: 10.1128/mcb.13.2.1183-1193.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Sp1, a CAAT-binding factor, and the adenovirus major late promoter transcription factor interact with functional regions of the gamma-fibrinogen promoter.

Authors:  J G Morgan; G Courtois; G Fourel; L A Chodosh; L Campbell; E Evans; G R Crabtree
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

Review 2.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

3.  Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses.

Authors:  P F Johnson; W H Landschulz; B J Graves; S L McKnight
Journal:  Genes Dev       Date:  1987-04       Impact factor: 11.361

4.  Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells.

Authors:  H Baumann; C Richards; J Gauldie
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

Review 5.  Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses.

Authors:  N C Jones; P W Rigby; E B Ziff
Journal:  Genes Dev       Date:  1988-03       Impact factor: 11.361

6.  A cell-specific enhancer of the mouse alpha 1-antitrypsin gene has multiple functional regions and corresponding protein-binding sites.

Authors:  D R Grayson; R H Costa; K G Xanthopoulos; J E Darnell
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

7.  Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5' flanking regions.

Authors:  D M Fowlkes; N T Mullis; C M Comeau; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Authors:  K Ikebuchi; G G Wong; S C Clark; J N Ihle; Y Hirai; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  Induction of rat acute-phase proteins by interleukin 6 in vivo.

Authors:  T Geiger; T Andus; J Klapproth; T Hirano; T Kishimoto; P C Heinrich
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

10.  Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.

Authors:  M Kawano; T Hirano; T Matsuda; T Taga; Y Horii; K Iwato; H Asaoku; B Tang; O Tanabe; H Tanaka
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

View more
  19 in total

1.  Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver.

Authors:  T Alonzi; D Maritano; B Gorgoni; G Rizzuto; C Libert; V Poli
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Pleiotropic effects of HNF1A rs1183910 in a population-based study of 60,283 individuals.

Authors:  Kristine H Allin; Børge G Nordestgaard
Journal:  Diabetologia       Date:  2014-01-19       Impact factor: 10.122

Review 3.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

4.  A compilation of composite regulatory elements affecting gene transcription in vertebrates.

Authors:  O V Kel; A G Romaschenko; A E Kel; E Wingender; N A Kolchanov
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

5.  Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.

Authors:  J I Leu; M A Crissey; J P Leu; G Ciliberto; R Taub
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

6.  Interleukin-6 promotor polymorphisms and coronary vasospastic angina in Han Chinese.

Authors:  Ying Wang; Gang Li; Ya-Min Su; Hai-Yan Pan; Hai-Hua Geng; Meng-Kan Fan; Min Pan
Journal:  Int J Clin Exp Med       Date:  2014-09-15

7.  Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.

Authors:  Cara L Carty; Patrick Heagerty; Susan R Heckbert; Gail P Jarvik; Leslie A Lange; Mary Cushman; Russell P Tracy; Alexander P Reiner
Journal:  Ann Hum Genet       Date:  2010-01       Impact factor: 1.670

8.  Modification of the interleukin-6 response to air pollution by interleukin-6 and fibrinogen polymorphisms.

Authors:  Petter Ljungman; Tom Bellander; Alexandra Schneider; Susanne Breitner; Francesco Forastiere; Regina Hampel; Thomas Illig; Bénédicte Jacquemin; Klea Katsouyanni; Stephanie von Klot; Wolfgang Koenig; Timo Lanki; Fredrik Nyberg; Juha Pekkanen; Riccardo Pistelli; Christos Pitsavos; Mårten Rosenqvist; Jordi Sunyer; Annette Peters
Journal:  Environ Health Perspect       Date:  2009-04-06       Impact factor: 9.031

9.  Molecular analysis of the differential hepatic expression of rat kininogen family genes.

Authors:  H M Chen; W S Liao
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

10.  Roles of IL-6-gp130 Signaling in Vascular Inflammation.

Authors:  Tieying Hou; Brian C Tieu; Sutapa Ray; Adrian Recinos Iii; Ruwen Cui; Ronald G Tilton; Allan R Brasier
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.